{"member_organisations": "http://www.dndi.org/about-dndi/dndi-worldwide/ \n \nhttp://www.dndi.org/about-dndi/our-people/", "identification_number": "66666589895-96", "fields_of_interest": "International co-operation and development, Research and innovation, Public Health", "head_office_address": "Chemin Louis-Dunant, 15", "full_time_equivalent_fte": "20", "person_with_legal_responsibility": "Jean-Fran\u00e7ois Alesandrini", "inter_groups": "", "financial_year_start_date": "01/01/2016", "grants": "1373096", "head_office_country": "Switzerland", "eu_initiatives": "Advocacy of global policy related to neglected diseases;  political leadership, sustainable financing, and sound public policies for R&D in neglected diseases; treatment development for neglected diseases; strengthening of research capacities in low- and middle-income countries", "organisation_name": "Drugs for Neglected Diseases initiative (DNDi)", "belgium_office_post_code": "", "number_of_persons_involved": "20", "procurement": "", "section": "III - Non-governmental organisations", "source": "", "belgium_office_address": "", "subsection": "Non-governmental organisations, platforms and networks and similar", "belgium_office_phone": "", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "18/10/2012", "website_address": "http://www.dndi.org", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Geneva", "membership": "", "head_office_post_code": "1202", "goals__remit": "Founded in 2003 to address the needs of patients with the most neglected diseases, DNDi is a collaborative, patients\u2019 needs-driven, not-for-profit drug R&D organization. \n \nVision \n \nTo improve the quality of life and the health of people suffering from neglected diseases by using an alternative model to develop drugs for these diseases and by ensuring equitable access to new and field-relevant health tools. \n \nIn this not-for-profit model, driven by the public sector, a variety of players collaborate to raise awareness of the need to research and develop drugs for those neglected diseases that fall outside the scope of market-driven R&D. They also build public responsibility and leadership in addressing the needs of these patients.", "industry_forums": "", "head_office_phone": "(+41)229069230", "level_of_interest": "global", "relevant_communication": "", "financial_year_end_date": "01/12/2016", "estimate_of_costs_as_a_range": "0-9999", "overall_budget_turnover_absolute_amount": "43291243", "legal_status": "not-for-profit foundation", "person_in_charge_of_eu_relations": "Annette Mahon", "customers": "", "belgium_office_post_box": "", "position": "External Relations Manager"}